eureKARE Joins DNA Storage Alliance

eureKARE, focusing on financing and building next generation biotechnology companies in the fields of synthetic biology and the microbiome, has joined the DNA Data Storage Alliance.

Formed in October 2020 by Illumina, Inc., Microsoft Corp., Twist Bioscience Corp. and Western Digital Corp., the alliance is the world’s first and most extensive alliances of industry and academic organizations in DNA storage. It shares a mission to create and promote an interoperable storage ecosystem based on DNA as a storage medium. This is done via public education, awareness raising, and the publication of white papers outlining the technology and its potential uses. Membership consists of a diverse range of stakeholders, combining a range of expertise essential for DNA storage.

Kristin Thompson, chief business officer, eureKARE, commented: “We are delighted to be joining the DNA storage Alliance. It is clear to us that the storing of digital data is a major challenge for our generation and one that we hope to address by investing in DNA storage approaches. DNA is a wonderful, eco-friendly solution to this problem due to its extremely dense nature. The market demand for a sustainable, low-cost approach, such as DNA storage is anticipated to grow exponentially in the next few years and this technology truly has the ability to revolutionize our lives. Working together to create the architecture needed to read, store, and write data is an essential first step.“

eureKARE is a stakeholder in the DNA storage space and aims to invest in opportunities that address the challenge of the growth in digital data through the use of DNA storage to protect digital information. It has a understanding of the importance of archiving and safeguarding data, due to the mining of large data sets for the company’s own AI driven tool, eureK[AI].

Storage and access of data is becoming an increasingly recognized challenge as massive amounts of digital data continue to be produced. DNA offers properties which provides a solution to this problem; it naturally writes and stores data that can be accessed centuries later with high stability. In addition, the compact size and low energy requirements of DNA are also attractive benefits, as current needs for storage require amounts of energy and space.

About eureKARE
It is an investment company dedicated to developing next gen biotechnology companies in the fields of synthetic biology and the microbiome. It has a 2-step investment approach to deliver long-term value creation. It supports translational research by creating and financing new companies out of high value European innovation through its biotech start-up studios eureKABIOME (Microbiome) and eureKASYNBIO (Synthetic biology). It also intends to invest in more mature biotech companies and will systematically propose to offer some liquidity to early investors, thereby addressing a need in the European biotech field. Guided by its ifounder, Alexandre Mouradian, and a pan-European team, eureKARE has a growing portfolio of companies that have the potential to change the life sciences industry.